Significant response of pulmonary sarcomatoid carcinoma with obstructive atelectasis to treatment with the PD-1 inhibitor camrelizumab combined with transbronchial cryoablation: A case report and literature review

Pulmonary sarcomatoid carcinoma (PSC) is a rare subtype of non-small cell lung cancer with high malignancy and poor prognosis. Chemotherapy or radiotherapy do not usually provide satisfactory results in patients with PSC, especially in those with advanced-stage cancer. Targeted therapy and immunothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Nian, Jiayun, Zhu, Yong, Fu, Qi, Yang, Guowang, Wang, Xiaomin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646958/
https://www.ncbi.nlm.nih.gov/pubmed/36387200
http://dx.doi.org/10.3389/fonc.2022.1013047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646958/
https://www.ncbi.nlm.nih.gov/pubmed/36387200
http://dx.doi.org/10.3389/fonc.2022.1013047

Ejemplares similares